Literature DB >> 30556140

Altered T cell receptor beta repertoire patterns in pediatric ulcerative colitis.

L Werner1,2, M Y Nunberg1,2, E Rechavi2,3,4,5, A Lev2,3,4,5, T Braun1,2, Y Haberman1,2, A Lahad1,2, E Shteyer6, M Schvimer7, R Somech2,3,4,5, B Weiss1,2, Y N Lee2,3,4,5, D S Shouval1,2.   

Abstract

The antigenic specificity of T cells occurs via generation and rearrangement of different gene segments producing a functional T cell receptor (TCR). High-throughput sequencing (HTS) allows in-depth assessment of TCR repertoire patterns. There are limited data concerning whether TCR repertoires are altered in inflammatory bowel disease. We hypothesized that pediatric ulcerative colitis (UC) patients possess unique TCR repertoires, resulting from clonotypical expansions in the gut. Paired blood and rectal samples were collected from nine newly diagnosed treatment-naive pediatric UC patients and four healthy controls. DNA was isolated to determine the TCR-β repertoire by HTS. Significant clonal expansion was demonstrated in UC patients, with inverse correlation between clinical disease severity and repertoire diversity in the gut. Using different repertoire variables in rectal biopsies, a clear segregation was observed between patients with severe UC, those with mild-moderate disease and healthy controls. Moreover, the overlap between autologous blood-rectal samples in UC patients was significantly higher compared with overlap among controls. Finally, we identified several clonotypes that were shared in either all or the majority of UC patients in the colon. Clonal expansion of TCR-β-expressing T cells among UC patients correlates with disease severity and highlights their involvement in mediating intestinal inflammation.
© 2018 British Society for Immunology.

Entities:  

Keywords:  IBD; T cells; TCR; UC; mucosal immunity; repertoire

Mesh:

Substances:

Year:  2019        PMID: 30556140      PMCID: PMC6422658          DOI: 10.1111/cei.13247

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  5 in total

1.  Circulating α4β7+ Memory T Cells in Pediatric IBD Patients Express a Polyclonal T Cell Receptor Repertoire.

Authors:  Adir Gamliel; Lael Werner; Marina Pinsker; Naomi Salamon; Batia Weiss; Dror S Shouval
Journal:  Clin Exp Gastroenterol       Date:  2020-10-02

2.  Repertoire analysis of memory T-cell receptors in Japanese patients with inflammatory bowel disease.

Authors:  Yoichi Kakuta; Takeru Nakano; Takeo Naito; Kazuhiro Watanabe; Yasuhiro Izumiyama; Daisuke Okamoto; Ryo Ichikawa; Rintaro Moroi; Masatake Kuroha; Yoshitake Kanazawa; Tomoya Kimura; Hisashi Shiga; Takeshi Naitoh; Yoshitaka Kinouchi; Michiaki Unno; Atsushi Masamune
Journal:  JGH Open       Date:  2020-02-06

3.  High Frequency of Shared Clonotypes in Human T Cell Receptor Repertoires.

Authors:  Cinque Soto; Robin G Bombardi; Morgan Kozhevnikov; Robert S Sinkovits; Elaine C Chen; Andre Branchizio; Nurgun Kose; Samuel B Day; Mark Pilkinton; Madhusudan Gujral; Simon Mallal; James E Crowe
Journal:  Cell Rep       Date:  2020-07-14       Impact factor: 9.423

4.  Single-cell analysis shows that adipose tissue of persons with both HIV and diabetes is enriched for clonal, cytotoxic, and CMV-specific CD4+ T cells.

Authors:  Celestine N Wanjalla; Wyatt J McDonnell; Ramesh Ram; Abha Chopra; Rama Gangula; Shay Leary; Mona Mashayekhi; Joshua D Simmons; Christian M Warren; Samuel Bailin; Curtis L Gabriel; Liang Guo; Briana D Furch; Morgan C Lima; Beverly O Woodward; LaToya Hannah; Mark A Pilkinton; Daniela T Fuller; Kenji Kawai; Renu Virmani; Aloke V Finn; Alyssa H Hasty; Simon A Mallal; Spyros A Kalams; John R Koethe
Journal:  Cell Rep Med       Date:  2021-02-16

5.  Alterations in T and B Cell Receptor Repertoires Patterns in Patients With IL10 Signaling Defects and History of Infantile-Onset IBD.

Authors:  Lael Werner; Yu Nee Lee; Erez Rechavi; Atar Lev; Baruch Yerushalmi; Galina Ling; Neil Shah; Holm H Uhlig; Batia Weiss; Raz Somech; Scott B Snapper; Dror S Shouval
Journal:  Front Immunol       Date:  2020-02-06       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.